US Not Liable In Moderna Covid-19 Vaccine Patent Case: Second Judge

A Moderna spokesperson said in a statement that the company "respectfully disagrees" with the decision and is confident that discovery will support its position. Representatives for Alnylam did not immediately respond to a request for comment.

Leveraging Pharma From 4 Lakh Cr Market To 10 Lakh Cr: Modi

The Prime Minister suggested the pharma sectors identify important areas for investment

Research & Innovation Necessary For Sustained Growth Of Pharma: Mandaviya

Our focus must shift from self-sustenance model to profit model through expanding research base, creating industry connect, ramping up infrastructure

Centre Announces Three Schemes For Pharmaceutical MSMEs

The scheme is aimed at creating a database of pharma and medical device sectors. Mandaviya asked the industry to keep upgrading in order to cater to evolving requirements across global markets

Govt Continuously Working To Improve Ease Of Doing Biz In Pharma Sector: Minister

'Indian pharma industry can achieve the ambitious target which it has set for itself for reaching an annual turnover of USD 130 billion by 2030. Similarly, the medical device industry in the country has the potential to grow to about USD 50 billion by 2025,'

Karnataka to set up 2,500 smart classrooms for digital learning in next 2 months

Karnataka to set up 2,500 smart classrooms for digital learning in next 2 months

Sun Pharma Tumbles After Report Of Probe

Markets regulator Securities and Exchange Board of India (SEBI) is likely to reopen an insider trading case against Sun, media sources reported

SC Seeks Centre's Response On Faulty Hip Implants By Johnson & Johnson

Seeking Centre's response on faulty hip implants by Johnson & Johnson, a 3 judge bench of Supreme Court has asked to be apprised within 2 months about the actions taken after an expert committee found the pharma firms guilty of "medical negligence"

Lupin Trains Students To Reduce Skill Gap In The Company

The company graduates the students through its 'Learn and Earn' initiative for a three-year course

HC Suspends Till Oct Centre's Ban on Oxytocin drug production & Sale by Pvt Firms, Next Hearing on Sep 12

HC's interim ban comes on pleas by private firms seeking to set aside the Government's ban on Oxytocin drug production and sale which was to come into effect from tomorrow.

Job Seekers Looking For Flexible Career Options In India: Indeed Report

An annual study undertaken by 'Indeed' globally noted that Indian job seekers put flexibility at a premium with searches for 'work from home' increasing 111 per cent in 2017

Pharma Sector Needs To Double Its Size: Ananth Kumar